High Prevalence of Haemophilus ducreyi Among Patients With Suspected Primary syphilis in Malawi, 2019-2022

2019-2022年马拉维疑似原发性梅毒患者中杜克雷嗜血杆菌高流行率

阅读:2

Abstract

BACKGROUND: As syphilis rates have increased globally, chancroid has dramatically declined as a cause of genital ulcer disease (GUD). METHODS: We recruited patients aged ≥18 years presenting to a sexually transmitted infection clinic with GUD from Lilongwe, Malawi, from November 2019 through April 2022. Lesion exudates were tested by darkfield microscopy (DFM) and polymerase chain reaction (PCR) for Treponema pallidum (TP) and by PCR for Haemophilus ducreyi (HD), herpes simplex virus, and Chlamydia trachomatis. We evaluated the sensitivity and specificity of DFM relative to TP PCR, the distribution of GUD etiologies by PCR, and the performance of our HD PCR relative to Allplex Genital Ulcer assay (Seegene Inc) using the Cohen's kappa statistic. RESULTS: We enrolled 568 participants; the median age was 27 years (interquartile range: 23, 34), 61% (345/564) were men, and 13% (60/464) had human immunodeficiency virus (HIV) or were newly diagnosed with HIV. DFM identified TP in 55 (10%) participants, with a sensitivity and specificity of 12% and 94%, respectively. PCR identified TP in 367 (65%), HD in 128 (23%), herpes simplex virus in 98 (17%), and Chlamydia trachomatis in 36 (6%) of participants with only 1/36 (2.8%) with serovar L1, L2, or L3 consistent with lymphogranuloma venereum; no etiology was identified in 48 (8%). External validation confirmed the high HD prevalence (Cohen's kappa 0.78, 89% agreement). CONCLUSIONS: Syphilis and chancroid are common etiologies of GUD in Malawi. Our findings underscore the value of highly sensitive molecular diagnostic methods to periodically assess GUD causes among patients with sexually transmitted infections in countries using syndromic management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。